BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pu C, Chang S, Sun J, Zhu S, Liu H, Zhu Y, Wang Z, Xu RX. Ultrasound-mediated destruction of LHRHa-targeted and paclitaxel-loaded lipid microbubbles for the treatment of intraperitoneal ovarian cancer xenografts. Mol Pharm 2014;11:49-58. [PMID: 24237050 DOI: 10.1021/mp400523h] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen K, Hsu P, Huang H, Liu H, Lin Y, Hsu C, Lin J, Lin Y. Targeting nanoparticle-conjugated microbubbles combined with ultrasound-mediated microbubble destruction for enhanced tumor therapy. Pharmacological Research 2022;186:106532. [DOI: 10.1016/j.phrs.2022.106532] [Reference Citation Analysis]
2 Wang Y, Tian J, Han Y, Liu Y, Chen S, Guo F. Evaluation of the potential of ultrasound-mediated drug delivery for the treatment of ovarian cancer through preclinical studies. Front Oncol 2022;12:978603. [DOI: 10.3389/fonc.2022.978603] [Reference Citation Analysis]
3 He J, Liu Z, Zhu X, Xia H, Gao H, Lu J. Ultrasonic Microbubble Cavitation Enhanced Tissue Permeability and Drug Diffusion in Solid Tumor Therapy. Pharmaceutics 2022;14:1642. [PMID: 36015267 DOI: 10.3390/pharmaceutics14081642] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Wang X, Dong H. A convergent synthetic platform for anticancer drugs formulation with nanoparticle delivery for the treatment and nursing care of glioma cancer. Process Biochemistry 2021;111:172-80. [DOI: 10.1016/j.procbio.2021.10.020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Jangjou A, Meisami AH, Jamali K, Niakan MH, Abbasi M, Shafiee M, Salehi M, Hosseinzadeh A, Amani AM, Vaez A. The promising shadow of microbubble over medical sciences: from fighting wide scope of prevalence disease to cancer eradication. J Biomed Sci 2021;28:49. [PMID: 34154581 DOI: 10.1186/s12929-021-00744-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
6 Saripilli1 R, Shirisha P. Echogenic bubbles: An new avenue for cancer therapy. IJT. [DOI: 10.52711/2231-3915.2021.00002] [Reference Citation Analysis]
7 Zhu X, Yan S, Xiao F, Xue M. PLGA nanoparticles delivering CPT-11 combined with focused ultrasound inhibit platinum resistant ovarian cancer. Transl Cancer Res 2021;10:1732-43. [PMID: 35116498 DOI: 10.21037/tcr-20-3171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Han W, Liu X, Wang L, Zhou X. Engineering of lipid microbubbles-coated copper and selenium nanoparticles: Ultrasound-stimulated radiation of anticancer activity ian human ovarian cancer cells. Process Biochemistry 2020;98:113-121. [DOI: 10.1016/j.procbio.2020.07.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Ahmadi A, Hosseini-Nami S, Abed Z, Beik J, Aranda-Lara L, Samadian H, Morales-Avila E, Jaymand M, Shakeri-Zadeh A. Recent advances in ultrasound-triggered drug delivery through lipid-based nanomaterials. Drug Discov Today 2020;25:2182-200. [PMID: 33010479 DOI: 10.1016/j.drudis.2020.09.026] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
10 Chandan R, Mehta S, Banerjee R. Ultrasound-Responsive Carriers for Therapeutic Applications. ACS Biomater Sci Eng 2020;6:4731-47. [PMID: 33455210 DOI: 10.1021/acsbiomaterials.9b01979] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 15.5] [Reference Citation Analysis]
11 Tavsan Z, Kayali HA. Protein Kinase C regulates the complex between cell membrane molecules in ovarian cancer. Process Biochemistry 2020;92:182-189. [DOI: 10.1016/j.procbio.2020.01.009] [Reference Citation Analysis]
12 Mohamed TM, Ji-bin LM, John REP. Recent Advances in Microbubble-Augmented Cancer Therapy. Advanced Ultrasound in Diagnosis and Therapy 2020;4:155. [DOI: 10.37015/audt.2020.200055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Ding Y, Cao Q, Qian S, Chen X, Xu Y, Chen J, Shen H. Optimized Anti-Prostate-Specific Membrane Antigen Single-Chain Variable Fragment-Loaded Nanobubbles as a Novel Targeted Ultrasound Contrast Agent for the Diagnosis of Prostate Cancer. J Ultrasound Med 2020;39:761-73. [PMID: 31702068 DOI: 10.1002/jum.15155] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
14 Gong Q, Gao X, Liu W, Hong T, Chen C. Drug-Loaded Microbubbles Combined with Ultrasound for Thrombolysis and Malignant Tumor Therapy. Biomed Res Int 2019;2019:6792465. [PMID: 31662987 DOI: 10.1155/2019/6792465] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
15 Fu JW, Lin YS, Gan SL, Li YR, Wang Y, Feng ST, Li H, Zhou GF. Multifunctionalized Microscale Ultrasound Contrast Agents for Precise Theranostics of Malignant Tumors. Contrast Media Mol Imaging 2019;2019:3145647. [PMID: 31360144 DOI: 10.1155/2019/3145647] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
16 Qu N, Shi D, Shang M, Duan S, Guo L, Ning S, Li J. Breast Cancer Cell Line Phenotype Affects Sonoporation Efficiency Under Optimal Ultrasound Microbubble Conditions. Med Sci Monit 2018;24:9054-62. [PMID: 30546004 DOI: 10.12659/MSM.910790] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
17 Skachkov I, Luan Y, van Tiel ST, van der Steen AFW, de Jong N, Bernsen MR, Kooiman K. SPIO labeling of endothelial cells using ultrasound and targeted microbubbles at diagnostic pressures. PLoS One 2018;13:e0204354. [PMID: 30235336 DOI: 10.1371/journal.pone.0204354] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Gao Y, Chen S, Li W, Wang H, Xiao K, Wu L, Li Y, Li H, Li H, Zhu Y. An experimental study of ovarian cancer imaging and therapy by paclitaxel-loaded phase-transformation lipid nanoparticles combined with low-intensity focused ultrasound. Biochem Biophys Res Commun 2018;504:203-10. [PMID: 30180951 DOI: 10.1016/j.bbrc.2018.08.156] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
19 van den Brand D, Mertens V, Massuger LF, Brock R. siRNA in ovarian cancer – Delivery strategies and targets for therapy. Journal of Controlled Release 2018;283:45-58. [DOI: 10.1016/j.jconrel.2018.05.012] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
20 Roy J, Kaake M, Srinivasarao M, Low PS. Targeted Tubulysin B Hydrazide Conjugate for the Treatment of Luteinizing Hormone-Releasing Hormone Receptor-Positive Cancers. Bioconjugate Chem 2018;29:2208-14. [DOI: 10.1021/acs.bioconjchem.8b00164] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
21 Shi F, Li M, Wang J, Wu D, Pan M, Guo M, Dou J. Induction of multiple myeloma cancer stem cell apoptosis using conjugated anti-ABCG2 antibody with epirubicin-loaded microbubbles. Stem Cell Res Ther 2018;9:144. [PMID: 29784015 DOI: 10.1186/s13287-018-0885-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
22 Jang KW, Seol D, Ding L, Lim TH, Frank JA, Martin JA. Ultrasound-Mediated Microbubble Destruction Suppresses Melanoma Tumor Growth. Ultrasound Med Biol 2018;44:831-9. [PMID: 29361373 DOI: 10.1016/j.ultrasmedbio.2017.12.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
23 Jang KW, Seol D, Ding L, Heo DN, Lee SJ, Martin JA, Kwon IK. Ultrasound-triggered PLGA microparticle destruction and degradation for controlled delivery of local cytotoxicity and drug release. Int J Biol Macromol 2018;106:1211-7. [PMID: 28851638 DOI: 10.1016/j.ijbiomac.2017.08.125] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
24 Shi F, Li M, Wu S, Yang F, Di W, Pan M, Zhao F, Luo S, Gu N, Dou J. Enhancing the anti-multiple myeloma efficiency in a cancer stem cell xenograft model by conjugating the ABCG2 antibody with microbubbles for a targeted delivery of ultrasound mediated epirubicin. Biochem Pharmacol 2017;132:18-28. [PMID: 28232025 DOI: 10.1016/j.bcp.2017.02.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
25 Zhou S, Zhang X, Wang C. Rituximab-conjugated, doxorubicin-loaded microbubbles as a theranostic modality in B-cell lymphoma. Oncotarget 2017;8:4760-72. [PMID: 27902473 DOI: 10.18632/oncotarget.13587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
26 Luo T, Sun J, Zhu S, He J, Hao L, Xiao L, Zhu Y, Wang Q, Pan X, Wang Z, Chang S. Ultrasound-mediated destruction of oxygen and paclitaxel loaded dual-targeting microbubbles for intraperitoneal treatment of ovarian cancer xenografts. Cancer Lett 2017;391:1-11. [PMID: 28043912 DOI: 10.1016/j.canlet.2016.12.032] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 5.8] [Reference Citation Analysis]
27 Sennoga CA, Kanbar E, Auboire L, Dujardin P, Fouan D, Escoffre J, Bouakaz A. Microbubble-mediated ultrasound drug-delivery and therapeutic monitoring. Expert Opinion on Drug Delivery 2016;14:1031-43. [DOI: 10.1080/17425247.2017.1266328] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 11.3] [Reference Citation Analysis]
28 Ye H, Liu X, Sun J, Zhu S, Zhu Y, Chang S. Enhanced therapeutic efficacy of LHRHa-targeted brucea javanica oil liposomes for ovarian cancer. BMC Cancer. 2016;16:831. [PMID: 27793127 DOI: 10.1186/s12885-016-2870-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
29 van Rooij T, Skachkov I, Beekers I, Lattwein KR, Voorneveld JD, Kokhuis TJ, Bera D, Luan Y, van der Steen AF, de Jong N, Kooiman K. Viability of endothelial cells after ultrasound-mediated sonoporation: Influence of targeting, oscillation, and displacement of microbubbles. Journal of Controlled Release 2016;238:197-211. [DOI: 10.1016/j.jconrel.2016.07.037] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 10.2] [Reference Citation Analysis]
30 Shi D, Guo L, Duan S, Shang M, Meng D, Cheng L, Li J. Influence of tumor cell lines derived from different tissue on sonoporation efficiency under ultrasound microbubble treatment. Ultrason Sonochem 2017;38:598-603. [PMID: 27562907 DOI: 10.1016/j.ultsonch.2016.08.022] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
31 Fan X, Guo Y, Wang L, Xiong X, Zhu L, Fang K. Diagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubbles. Int J Nanomedicine 2016;11:3939-50. [PMID: 27574424 DOI: 10.2147/IJN.S112951] [Cited by in Crossref: 34] [Cited by in F6Publishing: 41] [Article Influence: 5.7] [Reference Citation Analysis]
32 Yang L, Moghaddas S, Dezvareh H, Belkacemi L, Bark SJ, Bose RN, Do LH. Insights into the anti-angiogenic properties of phosphaplatins. J Inorg Biochem 2016;164:5-16. [PMID: 27591123 DOI: 10.1016/j.jinorgbio.2016.07.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
33 Cao LB, Zeng S, Zhao W. Highly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers. Nanoscale Res Lett 2016;11:305. [PMID: 27325521 DOI: 10.1186/s11671-016-1509-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
34 Wang P, Yin T, Li J, Zheng B, Wang X, Wang Y, Zheng J, Zheng R, Shuai X. Ultrasound-responsive microbubbles for sonography-guided siRNA delivery. Nanomedicine: Nanotechnology, Biology and Medicine 2016;12:1139-49. [DOI: 10.1016/j.nano.2015.12.361] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 5.5] [Reference Citation Analysis]
35 Zhu Z, Si T, Xu RX. Microencapsulation of indocyanine green for potential applications in image-guided drug delivery. Lab Chip 2015;15:646-9. [PMID: 25450664 DOI: 10.1039/c4lc01032a] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 6.5] [Reference Citation Analysis]
36 Si T, Li G, Wu Q, Zhu Z, Luo X, Xu RX. Optical droplet vaporization of nanoparticle-loaded stimuli-responsive microbubbles. Appl Phys Lett 2016;108:111109. [DOI: 10.1063/1.4944539] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
37 Qin J, Wang TY, Willmann JK. Sonoporation: Applications for Cancer Therapy. Adv Exp Med Biol 2016;880:263-91. [PMID: 26486343 DOI: 10.1007/978-3-319-22536-4_15] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
38 Chang S, Si T, Zhang S, Merrick MA, Cohn DE, Xu RX. Ultrasound mediated destruction of multifunctional microbubbles for image guided delivery of oxygen and drugs. Ultrasonics Sonochemistry 2016;28:31-8. [DOI: 10.1016/j.ultsonch.2015.06.024] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
39 Raavé R, de Vries RB, Massuger LF, van Kuppevelt TH, Daamen WF. Drug delivery systems for ovarian cancer treatment: a systematic review and meta-analysis of animal studies. PeerJ 2015;3:e1489. [PMID: 26713240 DOI: 10.7717/peerj.1489] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
40 Sun J, Yin M, Zhu S, Liu L, Zhu Y, Wang Z, Xu RX, Chang S. Ultrasound-mediated destruction of oxygen and paclitaxel loaded lipid microbubbles for combination therapy in hypoxic ovarian cancer cells. Ultrason Sonochem 2016;28:319-26. [PMID: 26384914 DOI: 10.1016/j.ultsonch.2015.08.009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
41 Zhang Y, Chang S, Sun J, Zhu S, Pu C, Li Y, Zhu Y, Wang Z, Xu RX. Targeted Microbubbles for Ultrasound Mediated Short Hairpin RNA Plasmid Transfection to Inhibit Survivin Gene Expression and Induce Apoptosis of Ovarian Cancer A2780/DDP Cells. Mol Pharmaceutics 2015;12:3137-45. [DOI: 10.1021/mp500835z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
42 Lammertink BHA, Bos C, Deckers R, Storm G, Moonen CTW, Escoffre J. Sonochemotherapy: from bench to bedside. Front Pharmacol 2015;6. [DOI: 10.3389/fphar.2015.00138] [Cited by in Crossref: 64] [Cited by in F6Publishing: 68] [Article Influence: 9.1] [Reference Citation Analysis]
43 Hooker BA, Blomme EA. Targeted drug delivery in oncology: where drug discovery meets physics. Vet J 2015;205:120-1. [PMID: 26021890 DOI: 10.1016/j.tvjl.2015.04.034] [Reference Citation Analysis]
44 Liu L, Chang S, Sun J, Zhu S, Yin M, Zhu Y, Wang Z, Xu RX. Ultrasound-mediated destruction of paclitaxel and oxygen loaded lipid microbubbles for combination therapy in ovarian cancer xenografts. Cancer Lett 2015;361:147-54. [PMID: 25754815 DOI: 10.1016/j.canlet.2015.02.052] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 6.0] [Reference Citation Analysis]
45 van Rooij T, Daeichin V, Skachkov I, de Jong N, Kooiman K. Targeted ultrasound contrast agents for ultrasound molecular imaging and therapy. Int J Hyperthermia 2015;31:90-106. [PMID: 25707815 DOI: 10.3109/02656736.2014.997809] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 7.0] [Reference Citation Analysis]
46 Wen D, Chitkara D, Wu H, Danquah M, Patil R, Miller DD, Mahato RI. LHRH-Conjugated Micelles for Targeted Delivery of Antiandrogen to Treat Advanced Prostate Cancer. Pharm Res 2014;31:2784-95. [DOI: 10.1007/s11095-014-1375-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]